Quality and Process Metrics Along the Cancer Continuum: Your Guide to Best Practice

Monday, October 19, 2026

2:30 PM - 3:30 PM PT

Location: Petree Hall C

Moderator(s)

Jessica H. Maxwell, MD

Associate Professor
University of Pittsburgh
Pittsburgh, Pennsylvania, United States

Panelist(s)

YD

Yusuf Dundar, MD

Associate Professor
Texas Tech University-Health Sciences Center
Lubbock, TX, United States
DK

Diana N. Kirke, MD MPhil

Assistant Professor
Icahn School of Medicine at Mount Sinai
New York, NY, United States
Patrick T. Tassone, MD

Associate Professor of Otolaryngology
University of Missouri
Columbia, Missouri, United States

Disclosure(s):

Yusuf Dundar, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Diana N. Kirke, MD MPhil:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Patrick T. Tassone, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Attendees will be introduced to and subsequently understand quality metrics across the cancer continuum including initiation of treatment for patients with newly diagnosed SCC of the head and neck, time to surgery, treatment package time, and potential avenues to reduce treatment delays. Following this there will be a discussion regarding initiating adjuvant post-operative radiation within six weeks of curative surgery. Finally there will also be a discussion regarding evidence-based guidelines for surveillance including best practices to address long-term mental and physical treatment effects and imaging modalities to identify early recurrences.

Learning Objectives:

Understand quality metrics surrounding the initiation of treatment for patients with newly diagnosed SCC of the head and neck, including time to surgery, treatment package time, and potential avenues to reduce treatment delays.
Discuss evidence-based quality metrics for initiating adjuvant post-operative radiation within six weeks of curative surgery, including the factors that are associated with delays and potential techniques to target high-risk individuals to reduce delays and improve outcomes.
Understand evidence-based guidelines for surveillance in patients who have undergone treatment for head and neck cancer, including best practices to address long-term mental and physical treatment effects and imaging modalities to identify early recurrences.